BNP Paribas Financial Markets Acquires 56,389 Shares of DaVita Inc. (NYSE:DVA)

BNP Paribas Financial Markets boosted its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 23.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 292,039 shares of the company's stock after acquiring an additional 56,389 shares during the period. BNP Paribas Financial Markets owned about 0.36% of DaVita worth $47,874,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Harvard Management Co. Inc. acquired a new stake in shares of DaVita in the 2nd quarter worth about $55,115,000. KBC Group NV increased its stake in shares of DaVita by 27.3% in the third quarter. KBC Group NV now owns 313,519 shares of the company's stock valued at $51,395,000 after purchasing an additional 67,250 shares during the period. Andra AP fonden raised its holdings in shares of DaVita by 9.0% during the second quarter. Andra AP fonden now owns 192,300 shares of the company's stock valued at $26,647,000 after buying an additional 15,800 shares during the last quarter. abrdn plc grew its holdings in DaVita by 1.2% in the 3rd quarter. abrdn plc now owns 189,065 shares of the company's stock worth $30,719,000 after buying an additional 2,180 shares in the last quarter. Finally, FMR LLC increased its position in DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company's stock valued at $29,082,000 after acquiring an additional 154,061 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now owns 837,835 shares of the company's stock, valued at $138,284,666.75. The trade was a 5.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on DVA. Bank of America increased their price target on DaVita from $139.00 to $145.00 and gave the stock an "underperform" rating in a research note on Wednesday, August 7th. Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a research note on Monday, October 7th. UBS Group raised their price objective on shares of DaVita from $169.00 to $175.00 and gave the company a "buy" rating in a research note on Thursday, August 8th. Finally, Barclays increased their price target on DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, DaVita presently has a consensus rating of "Hold" and an average price target of $161.80.

DaVita Trading Up 0.6 %

Shares of DaVita stock traded up $0.94 on Friday, reaching $166.57. 314,276 shares of the company were exchanged, compared to its average volume of 821,067. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. DaVita Inc. has a fifty-two week low of $99.18 and a fifty-two week high of $169.51. The firm has a market capitalization of $13.66 billion, a price-to-earnings ratio of 18.03, a price-to-earnings-growth ratio of 0.93 and a beta of 0.89. The stock has a fifty day moving average price of $158.52 and a 200-day moving average price of $149.10.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). The firm had revenue of $3.26 billion for the quarter, compared to analysts' expectations of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. DaVita's quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $2.85 earnings per share. On average, analysts expect that DaVita Inc. will post 9.71 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.